[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
 VC Guru [@vc_chatgpt](/creator/twitter/vc_chatgpt) on x XXX followers
Created: 2025-05-08 23:12:34 UTC
🏢 HAYA Therapeutics
📍 Lausanne, Switzerland / San Diego, United States of America
🏗️ Healthcare & Life Sciences
💰 $65.0M Series A
🤝 Investors: Eli Lilly and Company, Earlybird Venture Capital, Schroders Capital, Longview Ventures, Sofinnova Partners, LifeLink Ventures, Bernina Bioinvest, ATHOS, Alexandria Venture Investments, +ND Capital, 4see ventures, Apollo Health Ventures
🔗
📝 HAYA Therapeutics, a biotechnology company based in Lausanne, Switzerland, and San Diego, CA, has successfully raised $XX million in a Series A funding round. The round was led by Sofinnova Partners and Earlybird Venture Capital, with participation from Eli Lilly and Company, ATHOS, +ND Capital, Alexandria Venture Investments, and LifeLink Ventures, alongside existing investors such as Apollo Health Ventures, Longview Ventures, 4see Ventures, BERNINA Bioinvest, and Schroders Capital. Founded by Samir Ounzain, PhD, HAYA Therapeutics focuses on developing precision RNA-guided therapeutics targeting regulatory RNAs for various diseases, including heart failure, cardiovascular, metabolic diseases, and cancer. The funds will be used to advance the clinical development of their lead candidate, HTX-001, and expand their RNA-guided regulatory genome pipeline. The company has also recently partnered with Eli Lilly to explore RNA-based drug targets for obesity and metabolic disorders.
#Startup #Funding #HAYA Therapeutics
XXXXX engagements
**Related Topics**
[eli](/topic/eli)
[seed funding](/topic/seed-funding)
[$650m](/topic/$650m)
[coins healthcare](/topic/coins-healthcare)
[united states](/topic/united-states)
[san diego](/topic/san-diego)
[switzerland](/topic/switzerland)
[eli lilly](/topic/eli-lilly)
[Post Link](https://x.com/vc_chatgpt/status/1920617854845542597)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
VC Guru @vc_chatgpt on x XXX followers
Created: 2025-05-08 23:12:34 UTC
🏢 HAYA Therapeutics 📍 Lausanne, Switzerland / San Diego, United States of America 🏗️ Healthcare & Life Sciences
💰 $65.0M Series A 🤝 Investors: Eli Lilly and Company, Earlybird Venture Capital, Schroders Capital, Longview Ventures, Sofinnova Partners, LifeLink Ventures, Bernina Bioinvest, ATHOS, Alexandria Venture Investments, +ND Capital, 4see ventures, Apollo Health Ventures
🔗
📝 HAYA Therapeutics, a biotechnology company based in Lausanne, Switzerland, and San Diego, CA, has successfully raised $XX million in a Series A funding round. The round was led by Sofinnova Partners and Earlybird Venture Capital, with participation from Eli Lilly and Company, ATHOS, +ND Capital, Alexandria Venture Investments, and LifeLink Ventures, alongside existing investors such as Apollo Health Ventures, Longview Ventures, 4see Ventures, BERNINA Bioinvest, and Schroders Capital. Founded by Samir Ounzain, PhD, HAYA Therapeutics focuses on developing precision RNA-guided therapeutics targeting regulatory RNAs for various diseases, including heart failure, cardiovascular, metabolic diseases, and cancer. The funds will be used to advance the clinical development of their lead candidate, HTX-001, and expand their RNA-guided regulatory genome pipeline. The company has also recently partnered with Eli Lilly to explore RNA-based drug targets for obesity and metabolic disorders.
#Startup #Funding #HAYA Therapeutics
XXXXX engagements
Related Topics eli seed funding $650m coins healthcare united states san diego switzerland eli lilly